
SI-BONE Q3 revenue rises 15% to $55.7M; new Onyx device expands market to $5B
SI-BONE reported a 15% increase in third-quarter 2026 revenue to $55.7 million, driven by growing adoption of its surgical implants. The launch of the iFuse Granite Onyx device, approved by the FDA, expands the company's addressable market to $5 bill...





